| Net Cash Provided by (Used in) Operating Activities |
$510,734,000 |
USD |
3.1% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$431,953,000 |
USD |
9.7% |
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
203,377,000 |
shares |
40% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$79,050,000 |
USD |
41% |
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$181,356,000 |
USD |
-53% |
Q4 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$43,397,000 |
USD |
7.7% |
Q4 2025 |
Q1 2026 |
| Deferred Income Tax Expense (Benefit) |
$87,000 |
USD |
93% |
Q4 2025 |
Q1 2026 |
| Current Income Tax Expense (Benefit) |
$1,200,000 |
USD |
|
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$4,745,691,000 |
USD |
39% |
Q4 2025 |
Q1 2026 |
| Interest Expense |
$174,833,000 |
USD |
26% |
Q4 2025 |
Q1 2026 |